AlphaFold predicted structure
SLC30A9 · Q6PML9

Mean pLDDT
74.9/ 100
Confident
568 residues
Confidence breakdown
- Very high(≥ 90)45%
- Confident(70–90)27%
- Low(50–70)7%
- Very low(< 50)22%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 30 member 9
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Childhood onset dystonia, chorea or related movement disorder
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalpsychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome
hereditary disease
neurodegenerative disease
major depressive disorder
bipolar disorder
Abnormality of the skeletal system
autism spectrum disorder
anorexia nervosa
attention deficit-hyperactivity disorder
obsessive-compulsive disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Proton-coupled zinc antiporter SLC30A9, mitochondrial
Mitochondrial proton-coupled zinc ion antiporter mediating the export of zinc from the mitochondria and involved in zinc homeostasis, zinc mobilization as well as mitochondrial morphology and health (PubMed:28334855, PubMed:34397090, PubMed:34433664, PubMed:35614220). In nucleus, functions as a secondary coactivator for nuclear receptors by cooperating with p160 coactivators subtypes. Plays a role in transcriptional activation of Wnt-responsive genes (By similarity)
SLC30A9 · Q6PML9

Mean pLDDT
74.9/ 100
Confident
568 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0